bioXXmed AG (FRA:T5O)
Germany · Delayed Price · Currency is EUR 1.020
+0.020 (2.00%)
Last updated: Oct 6, 2026, 7:36 PM CET
bioXXmed AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| -0 | 0.02 | 0 | 0.02 | 0.01 | 0.04 | |
Revenue Growth | - | 378.99% | -79.93% | 42.27% | -72.59% | 23.96% |
Gross Profit | -0 | 0.02 | 0 | 0.02 | 0.01 | 0.04 |
Selling, General & Admin | 0.03 | 0.03 | 0.01 | 0.01 | 0 | 0.55 |
Other Operating Expenses | 0.14 | 0.26 | 0.86 | 0.82 | 0.83 | 1.01 |
Operating Expenses | 0.08 | 0.29 | 0.88 | 0.82 | 0.84 | 1.61 |
Operating Income | -0.09 | -0.27 | -0.87 | -0.81 | -0.82 | -1.57 |
Interest Expense | -0.01 | -0.01 | - | - | -0.04 | -0 |
Interest & Investment Income | 0 | 0 | - | 0.02 | 0.03 | 0 |
Other Non Operating Income (Expenses) | 0.01 | 0.01 | 0 | - | - | - |
EBT Excluding Unusual Items | -0.08 | -0.27 | -0.87 | -0.79 | -0.83 | -1.57 |
Gain (Loss) on Sale of Investments | -0.1 | -0.1 | -0.13 | -20.16 | - | -2.49 |
Pretax Income | -0.18 | -0.37 | -1 | -20.95 | -0.83 | -4.06 |
Income Tax Expense | -0 | -0 | - | - | - | - |
Net Income | -0.18 | -0.37 | -1 | -20.95 | -0.83 | -4.06 |
Net Income to Common | -0.18 | -0.37 | -1 | -20.95 | -0.83 | -4.06 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | - | 0 | 0 | 0 | 0 | 0 |
Shares Outstanding (Diluted) | - | 0 | 0 | 0 | 0 | 0 |
Shares Change | - | - | 164.59% | - | 27.54% | - |
EPS (Basic) | - | -1.34 | -3.67 | -203.88 | -8.08 | -50.38 |
EPS (Diluted) | - | -1.34 | -3.67 | -203.88 | -8.08 | -50.38 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | -0.34 | -0.92 | -0.73 | -0.91 | - |
Free Cash Flow Per Share | - | -1.23 | -3.37 | -7.11 | -8.90 | - |
Gross Margin | - | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | - | -1621.11% | -24950.87% | -4633.08% | -6727.67% | -3516.49% |
Profit Margin | - | -2183.91% | -28540.14% | -120369.63% | -6783.58% | -9095.43% |
Free Cash Flow Margin | - | -2002.27% | -26223.88% | -4194.44% | -7473.42% | - |
EBITDA | -0.09 | -0.27 | -0.87 | -0.81 | -0.82 | -1.55 |
D&A For EBITDA | 0 | 0 | 0 | 0 | 0.01 | 0.02 |
EBIT | -0.09 | -0.27 | -0.87 | -0.81 | -0.82 | -1.57 |